Oura’s public S-1 filing on September 3–4, 2026, disclosed $1.21 billion in revenue for the nine months ended June 30—an 74% year-over-year increase—with trailing-twelve-month revenue exceeding $1.4 billion and a shift to $60.8 million net income. This trajectory, driven by 3.1 million rings shipped and five million paid members generating high-margin recurring revenue, underpins market-implied odds clustering around the $15–17.5 billion and $20 billion-plus brackets. The company’s reported plans for a September Nasdaq listing (ticker OURA) targeting more than $16 billion valuation, up from the prior $11 billion private round, combined with a constructive IPO window and subscription economics near 89% gross margins, explain the tight contest among mid-to-high outcomes. Key swing factors include final pricing, secondary share sales, broader market sentiment toward health-tech multiples, and any pre-listing updates on retailer concentration or regulatory exposure.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$15B–$17.5B 31%
$20B+ 29%
$12.5B–$15B 22%
$17.5B–$20B 17%
$449,595 ปริมาณ
$449,595 ปริมาณ
<$7.5B
<1%
$7.5B–$10B
<1%
$10B–$12.5B
3%
$12.5B–$15B
22%
$15B–$17.5B
31%
$17.5B–$20B
17%
$20B+
29%
No IPO before January 2027
<1%
$15B–$17.5B 31%
$20B+ 29%
$12.5B–$15B 22%
$17.5B–$20B 17%
$449,595 ปริมาณ
$449,595 ปริมาณ
<$7.5B
<1%
$7.5B–$10B
<1%
$10B–$12.5B
3%
$12.5B–$15B
22%
$15B–$17.5B
31%
$17.5B–$20B
17%
$20B+
29%
No IPO before January 2027
<1%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
ตลาดเปิดเมื่อ: May 26, 2026, 12:28 PM ET
ผู้ตัดสินผล
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
ผู้ตัดสินผล
0x69c47De9D...Oura’s public S-1 filing on September 3–4, 2026, disclosed $1.21 billion in revenue for the nine months ended June 30—an 74% year-over-year increase—with trailing-twelve-month revenue exceeding $1.4 billion and a shift to $60.8 million net income. This trajectory, driven by 3.1 million rings shipped and five million paid members generating high-margin recurring revenue, underpins market-implied odds clustering around the $15–17.5 billion and $20 billion-plus brackets. The company’s reported plans for a September Nasdaq listing (ticker OURA) targeting more than $16 billion valuation, up from the prior $11 billion private round, combined with a constructive IPO window and subscription economics near 89% gross margins, explain the tight contest among mid-to-high outcomes. Key swing factors include final pricing, secondary share sales, broader market sentiment toward health-tech multiples, and any pre-listing updates on retailer concentration or regulatory exposure.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว


ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย